Cancer Causes & Control

, Volume 19, Issue 10, pp 1383–1390 | Cite as

Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996–2001

  • Xue Qin YuEmail author
  • Dianne L. O’Connell
  • Robert W. Gibberd
  • Bruce K. Armstrong
Original Paper



To assess the impact of socio-economic status (SES) on cancer survival in the state of New South Wales (NSW), Australia.


Patients diagnosed with one of 13 major cancers during 1992–2000 in NSW were followed-up to the end of 2001. The effect of SES on survival was estimated for each individual cancer and all 13 cancers combined using multivariable modeling. The numbers of lives that could be extended if all people had the same level of excess risk of death due to cancer as patients in the highest SES areas were also estimated.


There were highly statistically significant variations in survival across SES groups for four cancers: stomach, liver, lung, and breast and all 13 cancers combined. Variation remained highly significant after adjusting for disease stage. Patients in lower SES areas had 10–20% higher excess risk than those in the highest SES areas. In total, there were 3,346 lives potentially extendable beyond 5 years; the highest number was for lung cancer (756).


The significantly worse survival in lower SES areas from cancers of the stomach, liver, lung, and breast may be due to poorer access to high-quality cancer care. Estimates of the number of lives potentially extendable by improving cancer survival in lower SES areas suggest that priority should be given to improving lung cancer care in lower SES areas in NSW, Australia.


Relative survival Relative excess risk Population-based cancer registry Disparities Socio-economic status 



We thank the reviewer for providing constructive comments, which led to significant improvements in the manuscript. We also thank the NSW Central Cancer Registry for providing data for this study. Bruce Armstrong’s research is supported by a University of Sydney Medical Foundation Program Grant.


  1. 1.
    Australian Institute of Health and Welfare, Australasian Association of Cancer Registries (2003) Cancer survival in Australia 1992–1997: geographic categories and socioeconomic status. Australian Institute of Health and Welfare, CanberraGoogle Scholar
  2. 2.
    Coleman MP, Babb P, Sloggett A, Quinn M, De Stavola B (2001) Socioeconomic inequalities in cancer survival in England and Wales. Cancer 91:208–216. doi :10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-EPubMedCrossRefGoogle Scholar
  3. 3.
    Dickman PW, Gibberd RW, Hakulinen T (1997) Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries. J Epidemiol Community Health 51:289–298PubMedCrossRefGoogle Scholar
  4. 4.
    Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY (2008) Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9:222–231. doi: 10.1016/S1470-2045(08)70032-9 PubMedCrossRefGoogle Scholar
  5. 5.
    Ward E, Halpern M, Schrag N et al (2008) Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 58:9–31PubMedCrossRefGoogle Scholar
  6. 6.
    Hall SE, Holman CD, Wisniewski ZS, Semmens J (2005) Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival. BJU Int 95:51–58. doi: 10.1111/j.1464-410X.2005.05248.x PubMedCrossRefGoogle Scholar
  7. 7.
    Morris M, Iacopetta B, Platell C (2007) Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals. Med J Aust 186:296–300PubMedGoogle Scholar
  8. 8.
    Yu XQ, O’Connell DL, Gibberd RW, Armstrong BK (2005) A population-based study from New South Wales, Australia 1996–2001: area variation in survival from colorectal cancer. Eur J Cancer 41:2715–2721. doi: 10.1016/j.ejca.2005.05.018 PubMedCrossRefGoogle Scholar
  9. 9.
    Percy C, Van Holten V, Muir C (eds) (1990) International classification of diseases for oncology, 2nd edn. World Health Organisation, Geneva, SwitzerlandGoogle Scholar
  10. 10.
    Australian Bureau of Statistics (1998) Information paper: 1996 census socio-economic indexes for areas (SEIFA). ABS, CanberraGoogle Scholar
  11. 11.
    Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds) (2001) SEER summary staging manual—2000: codes and coding instructions. National Cancer Institute, BethesdaGoogle Scholar
  12. 12.
    Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, PhiladelphiaGoogle Scholar
  13. 13.
    Berkson J, Gage RP (1950) Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin 25:270–286PubMedGoogle Scholar
  14. 14.
    Coleman M, Aylin P (eds) (2000) Death certification and mortality statistics: an international perspective. TSO, LondonGoogle Scholar
  15. 15.
    Percy C, Stanek E III, Gloeckler L (1981) Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71:242–250PubMedCrossRefGoogle Scholar
  16. 16.
    Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121PubMedGoogle Scholar
  17. 17.
    Chiang C (1968) Introduction to stochastic processes in biostatistics. Wiley, New YorkGoogle Scholar
  18. 18.
    Ederer F, Heise H (1959) Instructions to IMB 650 programmers in processing survival computations. Methodological note No. 10, End Results Evaluation Section. National Cancer Institute, BethesdaGoogle Scholar
  19. 19.
    Brenner H, Gefeller O (1996) An alternative approach to monitoring cancer patient survival. Cancer 78:2004–2010. doi :10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#PubMedCrossRefGoogle Scholar
  20. 20.
    Brenner H, Gefeller O (1997) Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 50:211–216. doi: 10.1016/S0895-4356(97)00280-1 PubMedCrossRefGoogle Scholar
  21. 21.
    Yu X, O’Connell D, Gibberd R, Smith D, Armstrong B (2003) Cancer survival, incidence and mortality by Area Health Service in NSW 1994 to 2000. The Cancer Council New South Wales, SydneyGoogle Scholar
  22. 22.
    Yu XQ, O’Connell DL, Forman D (2004) Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites. Br J Cancer 91:1663–1665PubMedGoogle Scholar
  23. 23.
    Yu XQ, O’Connell DL, Gibberd RW, Smith DP, Dickman PW, Armstrong BK (2004) Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes Control 15:611–618. doi: 10.1023/B:CACO.0000036165.13089.e8 PubMedCrossRefGoogle Scholar
  24. 24.
    Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40:2494–2501. doi: 10.1016/j.ejca.2004.07.022 PubMedCrossRefGoogle Scholar
  25. 25.
    Dickman PW, Sloggett A, Hills M, Hakulinen T (2004) Regression models for relative survival. Stat Med 23:51–64. doi: 10.1002/sim.1597 PubMedCrossRefGoogle Scholar
  26. 26.
    Jong KE, Smith DP, Yu XQ, O’Connell DL, Goldstein D, Armstrong BK (2004) Remoteness of residence and survival from cancer in New South Wales. Med J Aust 180:618–622PubMedGoogle Scholar
  27. 27.
    Department of Health and Aged Care (2001) Measuring remoteness: accessibility/remoteness index of Australia (ARIA). Department of Health and Aged Care, CanberraGoogle Scholar
  28. 28.
    Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 study. Lancet Oncol 8:773–783. doi: 10.1016/S1470-2045(07)70245-0 PubMedCrossRefGoogle Scholar
  29. 29.
    Darlow BA, Hutchinson JL, Simpson JM, Henderson-Smart DJ, Donoghue DA, Evans NJ (2005) Variation in rates of severe retinopathy of prematurity among neonatal intensive care units in the Australian and New Zealand Neonatal Network. Br J Ophthalmol 89:1592–1596. doi: 10.1136/bjo.2005.073650 PubMedCrossRefGoogle Scholar
  30. 30.
    Gibberd R, Hancock S, Howley P, Richards K (2004) Using indicators to quantify the potential to improve the quality of health care. Int J Qual Health Care 16(Suppl 1):i37–i43. doi: 10.1093/intqhc/mzh019 PubMedCrossRefGoogle Scholar
  31. 31.
    Howley PP, Gibberd R (2003) Using hierarchical models to analyse clinical indicators: a comparison of the gamma-Poisson and beta-binomial models. Int J Qual Health Care 15:319–329. doi: 10.1093/intqhc/mzg044 PubMedCrossRefGoogle Scholar
  32. 32.
    Simpson JM, Evans N, Gibberd RW, Heuchan AM, Henderson-Smart DJ (2003) Analysing differences in clinical outcomes between hospitals. Qual Saf Health Care 12:257–262. doi: 10.1136/qhc.12.4.257 PubMedCrossRefGoogle Scholar
  33. 33.
    Braaten T, Weiderpass E, Kumle M, Lund E (2005) Explaining the socioeconomic variation in cancer risk in the Norwegian Women and Cancer Study. Cancer Epidemiol Biomarkers Prev 14:2591–2597. doi: 10.1158/1055-9965.EPI-05-0345 PubMedCrossRefGoogle Scholar
  34. 34.
    Ekberg-Aronsson M, Nilsson PM, Nilsson JA, Pehrsson K, Lofdahl CG (2006) Socio-economic status and lung cancer risk including histologic subtyping—a longitudinal study. Lung Cancer 51:21–29. doi: 10.1016/j.lungcan.2005.08.014 PubMedCrossRefGoogle Scholar
  35. 35.
    Siahpush M, Singh GK (2002) Sociodemographic variations in breast cancer screening behavior among Australian women: results from the 1995 National Health Survey. Prev Med 35:174–180. doi: 10.1006/pmed.2002.1063 PubMedCrossRefGoogle Scholar
  36. 36.
    Subramanian SV, Chen JT, Rehkopf DH, Waterman PD, Krieger N (2006) Comparing individual- and area-based socioeconomic measures for the surveillance of health disparities: a multilevel analysis of Massachusetts births, 1989–1991. Am J Epidemiol 164:823–834. doi: 10.1093/aje/kwj313 PubMedCrossRefGoogle Scholar
  37. 37.
    Dalton SO, Ross L, During M et al (2007) Influence of socioeconomic factors on survival after breast cancer—a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. Int J Cancer 121:2524–2531. doi: 10.1002/ijc.22979 PubMedCrossRefGoogle Scholar
  38. 38.
    Hussain SK, Altieri A, Sundquist J, Hemminki K (2008) Influence of education level on breast cancer risk and survival in Sweden between 1990 and 2004. Int J Cancer 122:165–169. doi: 10.1002/ijc.23007 PubMedCrossRefGoogle Scholar
  39. 39.
    Hussain SK, Lenner P, Sundquist J, Hemminki K (2008) Influence of education level on cancer survival in Sweden. Ann Oncol 19:156–162. doi: 10.1093/annonc/mdm413 PubMedCrossRefGoogle Scholar
  40. 40.
    Hall S, Holman CD, Sheiner H, Hendrie D (2004) The influence of socio-economic and locational disadvantage on survival after a diagnosis of lung or breast cancer in Western Australia. J Health Serv Res Policy 9(Suppl 2):10–16. doi: 10.1258/1355819042248116 PubMedCrossRefGoogle Scholar
  41. 41.
    Woods LM, Rachet B, Coleman MP (2006) Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol 17:5–19. doi: 10.1093/annonc/mdj007 PubMedCrossRefGoogle Scholar
  42. 42.
    Vinod SK, Delaney GP, Bauman AE, Barton MB (2003) Lung cancer patterns of care in south western Sydney, Australia. Thorax 58:690–694. doi: 10.1136/thorax.58.8.690 PubMedCrossRefGoogle Scholar
  43. 43.
    Ayanian JZ, Kohler BA, Abe T, Epstein AM (1993) The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326–331. doi: 10.1056/NEJM199307293290507 PubMedCrossRefGoogle Scholar
  44. 44.
    Coker AL, Du XL, Fang S, Eggleston KS (2006) Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecol Oncol 102:278–284. doi: 10.1016/j.ygyno.2005.12.016 PubMedCrossRefGoogle Scholar
  45. 45.
    Hall SE, Holman CD, Sheiner H (2004) The influence of socio-economic and locational disadvantage on patterns of surgical care for lung cancer in Western Australia 1982–2001. Aust Health Rev 27:68–79PubMedCrossRefGoogle Scholar
  46. 46.
    Cartman ML, Hatfield AC, Muers MF, Peake MD, Haward RA, Forman D (2002) Lung cancer: district active treatment rates affect survival. J Epidemiol Community Health 56:424–429. doi: 10.1136/jech.56.6.424 PubMedCrossRefGoogle Scholar
  47. 47.
    Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J (2002) Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer 87:585–590. doi: 10.1038/sj.bjc.6600515 PubMedCrossRefGoogle Scholar
  48. 48.
    Rutqvist LE, Bern A (2006) Socioeconomic gradients in clinical stage at presentation and survival among breast cancer patients in the Stockholm area 1977–1997. Int J Cancer 119:1433–1439. doi: 10.1002/ijc.21949 PubMedCrossRefGoogle Scholar
  49. 49.
    Bouchardy C, Verkooijen HM, Fioretta G (2006) Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer 119:1145–1151. doi: 10.1002/ijc.21889 PubMedCrossRefGoogle Scholar
  50. 50.
    Chaudhry R, Goel V, Sawka C (2001) Breast cancer survival by teaching status of the initial treating hospital. CMAJ 164:183–188PubMedGoogle Scholar
  51. 51.
    Goldman DP, Smith JP (2002) Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci USA 99:10929–10934. doi: 10.1073/pnas.162086599 PubMedCrossRefGoogle Scholar
  52. 52.
    Lagerlund M, Hedin A, Sparen P, Thurfjell E, Lambe M (2000) Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med 31:417–428. doi: 10.1006/pmed.2000.0723 PubMedCrossRefGoogle Scholar
  53. 53.
    Kaffashian F, Godward S, Davies T, Solomon L, McCann J, Duffy SW (2003) Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer 89:1693–1696. doi: 10.1038/sj.bjc.6601339 PubMedCrossRefGoogle Scholar
  54. 54.
    Yu XQ, O’Connell DL, Gibberd RW, Abrahamowicz M, Armstrong BK (2008) Misclassification of colorectal cancer stage and area variation in survival. Int J Cancer 122:398–402. doi: 10.1002/ijc.23043 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Xue Qin Yu
    • 1
    • 2
    Email author
  • Dianne L. O’Connell
    • 1
  • Robert W. Gibberd
    • 3
  • Bruce K. Armstrong
    • 4
  1. 1.Cancer Council, New South WalesSydneyAustralia
  2. 2.Epidemiology and Surveillance ResearchAmerican Cancer SocietyAtlantaUSA
  3. 3.University of NewcastleNewcastleAustralia
  4. 4.The University of SydneySydneyAustralia

Personalised recommendations